Pyroxd1 is essential for murine viability with the homozygous N155S recurrent variant linked to myopathy, muscle hypotrophy and osteopenia

Frances J. Evesson(Harvard University), Scott C. Cooper(The University of Sydney), R. Bryan Sutton(Texas Tech University), Michaela Yuen(The University of Sydney), Peter J. Houweling(The University of Sydney), Gregory Dziaduch(Garvan Institute of Medical Research), Jesse R. Wark(Children's Medical Research Institute), Emma Kettle(Westmead Institute for Medical Research), Leonit Kiriaev(The University of Melbourne), Ignatius Mayo Aquino Pang(Children's Medical Research Institute), Ann‐Katrin Piper(The University of Sydney), Vanessa Jones(Children's Medical Research Institute), Heather Best(The University of Sydney), P. P. L. Tam(The University of Sydney), Frances A. Lemcket(Children's Medical Research Institute), Katharine Zhang(The University of Sydney), Isaac Scott(Texas Tech University), Himanshu Joshi(Children's Medical Research Institute), Mark E. Graham(Children's Medical Research Institute), Joe Yasa(Children's Medical Research Institute)
Cited by 0


Related Papers